Session Track · IDC 2027

Sclerosing Disorders at IDC 2027

Part of the IDC 2027 scientific programme · NH Villa Carpegna, Rome, Italy · June 21–23, 2027

About the Sclerosing Disorders Session

Sclerosing disorders, often characterized by abnormal collagen deposition, can significantly impact skin appearance and function. In dermatology, conditions like morphea (localized scleroderma) and systemic sclerosis (scleroderma) are notable examples. Morphea leads to thick, hardened patches on the skin, while systemic sclerosis may cause skin tightening, affecting mobility and quality of life.

In cosmetology, addressing the aesthetic concerns related to these disorders is crucial. Treatments often focus on improving skin texture and appearance through moisturizing agents, topical corticosteroids, and advanced procedures like laser therapy. Additionally, patient education about skincare routines is essential to manage symptoms effectively and enhance skin health. Collaborating with dermatologists ensures a holistic approach to care, combining medical and cosmetic interventions to improve patient outcomes.

Featured Speakers — Sclerosing Disorders 2027

Speaker lineup for this track will be announced soon.

Browse all speakers →

Recent Research Presented at Sclerosing Disorders Sessions

Selected abstracts from this track will be published here.

Related Scientific Sessions at IDC 2027

Why Attend the Sclerosing Disorders Conference 2027

Earn CPD Credit

Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.

Present Your Research

Oral and poster slots for original Sclerosing Disorders work, reviewed by the scientific committee.

Network Globally

Meet researchers, clinicians, and industry leaders from around the world across three days.

Publish & Get Indexed

Accepted abstracts appear in the indexed conference proceedings with a citable DOI.

Learn from Keynotes

Plenary lectures from leading voices shaping Sclerosing Disorders research and practice.

Hybrid Flexibility

Attend in person in Rome or join virtually — same programme, same certificate.

Join IDC 2027 for the Sclerosing Disorders track

Oral and poster slots for your work — in person in Rome or online. Not presenting? Attend as a delegate to learn from the field.

Sclerosing Disorders Conference 2027 — FAQs

What is the Sclerosing Disorders track at IDC 2027?

The Sclerosing Disorders track is a dedicated stream within IDC 2027 covering the latest research, clinical innovation, and best practice in Sclerosing Disorders. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.

Who should attend the Sclerosing Disorders sessions?

Researchers, clinicians, educators, doctoral students, and industry leaders with an interest in Sclerosing Disorders are all welcome — whether presenting or attending.

Can I present my research in the Sclerosing Disorders track?

Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.

Is virtual attendance available for Sclerosing Disorders sessions?

Yes. IDC 2027 is a hybrid conference — attend the Sclerosing Disorders track in person in Rome or join live online, with on-demand access afterward.

Join the IDC 2027 delegation

Rome · June 21–23, 2027 · Hybrid · in-person & virtual

Register as Delegate →

Attend without presenting.